With 3.84 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.38 million shares. The 52-week range on VYX shows that it touched its highest point at $15.34 and its lowest point at $10.87 during that stretch. It currently has a 1-year price target of $15.89. Beta for the stock currently stands at 1.57.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VYX was down-trending over the past week, with a drop of -4.96%, but this was down by -6.50% over a month. Three-month performance dropped to -20.69% while six-month performance fell -14.50%. The stock lost -21.66% in the past year, while it has lost -16.91% so far this year. A look at the trailing 12-month EPS for VYX yields -6.31 with Next year EPS estimates of 0.98. For the next quarter, that number is 0.08. This implies an EPS growth rate of 679.81% for this year and 30.02% for next year.
Float and Shares Shorts:
At present, 145.50 million VYX shares are outstanding with a float of 141.02 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VYX since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.04067797 being high and -$0.25932 being low. For VYX, this leads to a yearly average estimate of -$0.15. Based on analyst estimates, the high estimate for the next quarter is $0.16 and the low estimate is $0.15. The average estimate for the next quarter is thus $0.16.
